Quote this publication Share Print

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) associated or not with prior cytoreductive surgery - INAHTA Brief

Health technology assessment - Posted on Jun 21 2021

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) consists, after prior cytoreductive surgery (curative indications, peritoneal carcinomatosis) or not (preventive indications, for the said carcinomatosis), in delivering a heated chemotherapy treatment to the abdominal cavity.

The two objectives of this report were:

  • question 1: to assess the efficacy and safety of the HIPEC procedure associated or not with prior cytoreductive surgery in order to define which indications are approved/non-approved;
  • question 2: to define the conditions in which the HIPEC procedure is carried out associated or not with prior cytoreductive surgery, and of the ensuing hospitalisation; along with the preoperative preparation required and methods of post-hospitalisation follow-up.

Contact Us

Évaluation des actes professionnels